Curtis, Scott Wilson

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Curtis, Scott Wilson's trades of Antibe Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
147.30
Quantity 40,524 +39.7%
Value CA$2,643,175
Transaction date
Purchase
Price
404.16
Quantity 35,393 -27.3%
Value CA$3,463,520
Transaction date
Purchase
Price
52.67
Quantity 10,290 -10.6%
Value CA$1,897,759
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-07 2024-03-07
B Purchase
40,524 +39.7%
147.30
CA$2,643,175 		40,524 +39.7% 147.30 CA$2,643,175
2022-11-16 2022-11-15
B Purchase
35,393 -27.3%
404.16
CA$3,463,520 		35,393 -27.3% 404.16 CA$3,463,520
2022-07-12 2022-07-08
B Purchase
10,290 -10.6%
52.67
CA$1,897,759 		10,290 -10.6% 52.67 CA$1,897,759